Rogisen

1 caplet (850 mg) qDay

Prevention of macular degeneration, improvement of night vision

N/A

Pregnancy Category: N/A

Lactation: N/A

Pregnancy Categories

A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA:Information not available.

Metabolism: N/A

Excretion: N/A

Mechanism of Action

Proprietary blend of vitamins A, C, & E, zinc, selenium, copper, bilberry anthocyanin complex, lutein, & a mixed bioflavonoid complex

Zinc, lutein & antioxidants have been shown to reduce macular degeneration risk